HealthdirectFree Australian health advice you can count on.

( ARTG ) Arixtra is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery.,Arixtra is indicated for the prevention of venous thromboembolic even‍‍‍‍‍‍​​​‍​​​​​​ts (VTE) in patients undergoing abdominal surgery who are at risk of thromboembolic complications.,Arixtra is indicated for the treatment of acute deep venous thrombosis (DVT) and acute pulmonary embolism (PE).,Arixtra is indicated for the treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) for whom urgent (<120 min) invasive management (PCI) is not indicated.,Arixtra is indicated for the treatment of ST segment elevation myocardial infarction (STEMI) in patients who are managed without any form of initial reperfusion therapy.